FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 357:9-17 July 5, 2007 Number 1 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Editorial by Collins, J. A. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

ABSTRACT

Background Pregnancy rates in women of advanced maternal age undergoing in vitro fertilization (IVF) are disappointingly low. It has been suggested that the use of preimplantation genetic screening of cleavage-stage embryos for aneuploidies may improve the effectiveness of IVF in these women.

Methods We conducted a multicenter, randomized, double-blind, controlled trial comparing three cycles of IVF with and without preimplantation genetic screening in women 35 through 41 years of age. The primary outcome measure was ongoing pregnancy at 12 weeks of gestation. The secondary outcome measures were biochemical pregnancy, clinical pregnancy, miscarriage, and live birth.

Results Four hundred eight women (206 assigned to preimplantation genetic screening and 202 assigned to the control group) underwent 836 cycles of IVF (434 cycles with and 402 cycles without preimplantation genetic screening). The ongoing-pregnancy rate was significantly lower in the women assigned to preimplantation genetic screening (52 of 206 women [25%]) than in those not assigned to preimplantation genetic screening (74 of 202 women [37%]; rate ratio, 0.69; 95% confidence interval [CI], 0.51 to 0.93). The women assigned to preimplantation genetic screening also had a significantly lower live-birth rate (49 of 206 women [24%] vs. 71 of 202 women [35%]; rate ratio, 0.68; 95% CI, 0.50 to 0.92).

Conclusions Preimplantation genetic screening did not increase but instead significantly reduced the rates of ongoing pregnancies and live births after IVF in women of advanced maternal age. (Current Controlled Trials number, ISRCTN76355836 [controlled-trials.com] .)

Source Information

From the Center for Reproductive Medicine (S.M., M.T., J.W.A.V., S.R., F.V.) and the Department of Clinical Epidemiology and Biostatistics (J.C.K., P.M.B.), Academic Medical Center, University of Amsterdam, Amsterdam; the Section of Reproductive Medicine, Department of Obstetrics and Gynecology (M.T., J.E.-A., N.E.A.V., E.G.J.M.A., M.J.H.), and the Department of Genetics (B.S.-R., C.H.C.M.B.), University Medical Center Groningen, University of Groningen, Groningen; and the Department of Obstetrics and Gynecology, Onze Lieve Vrouwe Gasthuis, Amsterdam (H.R.V.) — all in the Netherlands.

Address reprint requests to Dr. Repping at the Center for Reproductive Medicine, Academic Medical Center, University of Amsterdam, P.O. Box 22700, 1100 DE Amsterdam, the Netherlands, or at s.repping{at}amc.uva.nl.

Full Text of this Article

Related Letters:

In Vitro Fertilization with Preimplantation Genetic Screening
Munné S., Cohen J., Simpson J. L., Wilton L. J., Handyside A. H., Thornhill A. R., Mastenbroek S., van der Veen F., Repping S.
Extract | Full Text | PDF  
N Engl J Med 2007; 357:1769-1771, Oct 25, 2007. Correspondence

This article has been cited by other articles:

• Devroey, P., Fauser, B.C.J.M., Diedrich, K., on behalf of the Evian Annual Reproduction (EVAR), (2009). Approaches to improve the diagnosis and management of infertility. Hum Reprod Update 15: 391-408 [Abstract] [Full Text]  
• Aarden, E., Van Hoyweghen, I., Vos, R., Horstman, K. (2009). Providing preimplantation genetic diagnosis in the United Kingdom, The Netherlands and Germany: a comparative in-depth analysis of health-care access. Hum Reprod 24: 1542-1547 [Abstract] [Full Text]  
• Hernandez, E. R. (2009). What next for preimplantation genetic screening? Beyond aneuploidy. Hum Reprod 24: 1538-1541 [Abstract] [Full Text]  
• Rubio, C., Gimenez, C., Fernandez, E., Vendrell, X., Velilla, E., Parriego, M., Rodrigo, L., for Spanish Interest Group in Preimplantation Gene, (2009). The importance of good practice in preimplanation genetic screening: critical viewpoints. Hum Reprod 0: dep188v1-dep188 [Full Text]  
• The ESHRE Capri Workshop Group, (2009). Intrauterine insemination. Hum Reprod Update 15: 265-277 [Abstract] [Full Text]  
• Beyer, C.E., Osianlis, T., Boekel, K., Osborne, E., Rombauts, L., Catt, J., Kralevski, V., Aali, B.S., Gras, L. (2009). Preimplantation genetic screening outcomes are associated with culture conditions. Hum Reprod 24: 1212-1220 [Abstract] [Full Text]  
• Meintjes, M., Chantilis, S. J., Ward, D. C., Douglas, J. D., Rodriguez, A. J., Guerami, A. R., Bookout, D. M., Barnett, B. D., Madden, J. D. (2009). A randomized controlled study of human serum albumin and serum substitute supplement as protein supplements for IVF culture and the effect on live birth rates. Hum Reprod 24: 782-789 [Abstract] [Full Text]  
• Desmyttere, S., De Schepper, J., Nekkebroeck, J., De Vos, A., De Rycke, M., Staessen, C., Liebaers, I., Bonduelle, M. (2009). Two-year auxological and medical outcome of singletons born after embryo biopsy applied in preimplantation genetic diagnosis or preimplantation genetic screening. Hum Reprod 24: 470-476 [Abstract] [Full Text]  
• Yanagimachi, R. (2009). Germ Cell Research: A Personal Perspective. Biol. Reprod. 80: 204-218 [Abstract] [Full Text]  
• Wells, D., Alfarawati, S., Fragouli, E. (2008). Use of comprehensive chromosomal screening for embryo assessment: microarrays and CGH. Mol Hum Reprod 14: 703-710 [Abstract] [Full Text]  
• Twisk, M., Mastenbroek, S., Hoek, A., Heineman, M.-J., van der Veen, F., Bossuyt, P. M., Repping, S., Korevaar, J. C. (2008). No beneficial effect of preimplantation genetic screening in women of advanced maternal age with a high risk for embryonic aneuploidy. Hum Reprod 23: 2813-2817 [Abstract] [Full Text]  
• Staessen, C., Verpoest, W., Donoso, P., Haentjens, P., Van der Elst, J., Liebaers, I., Devroey, P. (2008). Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer. Hum Reprod 23: 2818-2825 [Abstract] [Full Text]  
• Mastenbroek, S., Scriven, P., Twisk, M., Viville, S., Van der Veen, F., Repping, S. (2008). What next for preimplantation genetic screening? More randomized controlled trials needed?. Hum Reprod 23: 2626-2628 [Abstract] [Full Text]  
• Fauser, B. C.J.M. (2008). Preimplantation genetic screening: the end of an affair?. Hum Reprod 23: 2622-2625 [Full Text]  
• Fritz, M. A. (2008). Perspectives on the efficacy and indications for preimplantation genetic screening: where are we now?. Hum Reprod 23: 2617-2621 [Full Text]  
• Simpson, J. L. (2008). What next for preimplantation genetic screening? Randomized clinical trial in assessing PGS: necessary but not sufficient. Hum Reprod 23: 2179-2181 [Abstract] [Full Text]  
• Obradors, A., Fernandez, E., Oliver-Bonet, M., Rius, M., de la Fuente, A., Wells, D., Benet, J., Navarro, J. (2008). Birth of a healthy boy after a double factor PGD in a couple carrying a genetic disease and at risk for aneuploidy: Case Report. Hum Reprod 23: 1949-1956 [Abstract] [Full Text]  
• Yakin, K., Urman, B. (2008). What next for preimplantation genetic screening? A clinician's perspective. Hum Reprod 23: 1686-1690 [Abstract] [Full Text]  
• Vergouw, C.G., Botros, L.L., Roos, P., Lens, J.W., Schats, R., Hompes, P.G.A., Burns, D.H., Lambalk, C.B (2008). Metabolomic profiling by near-infrared spectroscopy as a tool to assess embryo viability: a novel, non-invasive method for embryo selection. Hum Reprod 23: 1499-1504 [Abstract] [Full Text]  
• Jansen, R. P.S., Bowman, M. C., de Boer, K. A., Leigh, D. A., Lieberman, D. B., McArthur, S. J. (2008). What next for preimplantation genetic screening (PGS)? Experience with blastocyst biopsy and testing for aneuploidy. Hum Reprod 23: 1476-1478 [Abstract] [Full Text]  
• Zosmer, A., Epstein, M., Al-Shawaf, T. (2008). Ethical recruitment of patients for PGS trial. Hum Reprod 23: 1472-1472 [Full Text]  
• Ankum, W. M., Reitsma, J. B., Offringa, M. (2008). Reply: Ethical recruitment of patients for PGS trial. Hum Reprod 23: 1472-1473 [Full Text]  
• The ESHRE Capri Workshop Group, (2008). Genetic aspects of female reproduction. Hum Reprod Update 0: dmn009v1-15 [Abstract] [Full Text]  
• Ogilvie, C. M. (2008). Preimplantation testing for chromosome aneuploidy. The Obstetrician and Gynaecologist 10: 88-92 [Abstract] [Full Text]  
• Combelles, C. M.H. (2008). What are the trade-offs between one-cell and two-cell biopsies of preimplantation embryos?. Hum Reprod 23: 493-498 [Full Text]  
• Weghofer, A., Munne, S., Brannath, W., Chen, S., Tomkin, G., Cekleniak, N., Garrisi, M., Barad, D., Cohen, J., Gleicher, N. (2008). The impact of LH-containing gonadotropins on diploidy rates in preimplantation embryos: long protocol stimulation. Hum Reprod 23: 499-503 [Abstract] [Full Text]  
• Harper, J., Sermon, K., Geraedts, J., Vesela, K., Harton, G., Thornhill, A., Pehlivan, T., Fiorentino, F., SenGupta, S., de Die-Smulders, C., Magli, C., Moutou, C., Wilton, L. (2008). What next for preimplantation genetic screening?. Hum Reprod 23: 478-480 [Abstract] [Full Text]  
• Ankum, W. M., Reitsma, J. B., Offringa, M. (2008). IVF with preimplantation genetic screening, a promising new treatment with unexpectedly negative health outcomes: the Hippocratic role of Data Monitoring Committees. Hum Reprod 23: 1-3 [Abstract] [Full Text]  
• Munne, S., Cohen, J., Simpson, J. L., Wilton, L. J., Handyside, A. H., Thornhill, A. R., Mastenbroek, S., van der Veen, F., Repping, S. (2007). In Vitro Fertilization with Preimplantation Genetic Screening. NEJM 357: 1769-1771 [Full Text]  
• Braude, P., Flinter, F. (2007). Use and misuse of preimplantation genetic testing. BMJ 335: 752-754 [Full Text]  
• (2007). Preimplantation Genetic Screening and Pregnancy Outcome. JWatch Women's Health 2007: 1-1 [Full Text]